84 research outputs found
Parametric study of an air charged Franchot engine with novel hot and cold isothermalisers
The Stirling engine is an external combustion engine that uses heat exchangers to enhance the addition and removal of energy. This makes the engine power-dense but expensive, less efficient and complicated. In this contribution, the Stirling engine based on the Franchot engine has novel cylindrical fins working as isothermalizers to improve heat transfer without the complications of heat exchangers. Enhancing the power density by isothermalizing work spaces is compared to the bare cylinder optimized by varying the phase angle. The theoretical analysis shows that both the adiabatic and isothermal fins increase the power and efficiency, achieving the Curzon and Ahlborn efficiency at the maximum power point. In comparison to the phase angle method, the finned engine resulted in much lower gas mass flow rate, which leads to a reduction in the regenerator pumping and enthalpy losses. Thus, the Stirling engine has the potential to be simple, cheap, efficient and power-dense, and thus can be used effectively for different applications
Theoretical investigation of the performance of an Alpha Stirling engine for low temperature applications
The purpose of this paper is to explore the applicability and peculiarities of Alpha engines at low heat source temperature levels of 100 to 200°C. A parameter study of an Alpha engine has been carried out using the commercial Stirling software Sage. The obtained results revealed some interesting insights into the peculiarities of low-temperature Alpha-SEs. A method for optimising the system design-parameters for a SE is described in this paper.
The compact design of a double-acting Alpha engine helps to reduce not only engine size and complexity but also costs. At low temperature differences single-cylinder displacer-type (gamma) engines are well documented, while little is known about the performance of Alpha multi-cylinder engines. In order to achieve the highest possible power output not only the thermodynamic side but also the mechanical side of the engine has to be optimised. This is especially important at low temperature differentials, where the conversion efficiencies are inherently small and the driving force for heat absorption and rejection by the working gas is low. It is mandatory not only to convert as much heat as possible to indicated work but also to transfer as much of this hard gained work to usable power output by minimising internal friction, when trying to keep the engine size as small as possible.
The indicated power output of an engine of a specific swept volume is dependent on the temperature and pressure levels, the frequency, the phase angle between the two pistons, the working fluid, and the design of the heat exchangers and the regenerator. A simple model of an Alpha engine was created using the commercial SE simulation tool Sage. In order to explore the relations between those parameters a model was developed, where the design parameters (temperature, mean pressure, frequency, and phase angle) were varied, and the heat exchangers and the regenerator were then optimised for each of the parameter combinations to reach the maximum power output. Temperature and mean pressure are shown to have the expected positive influence on the power output. For the frequency and the phase angle, optimum values can be found that differ significantly from those found for high temperature engines. Helium is used as the benchmark working gas. It can be shown that the use of Nitrogen instead cuts the power output in half, whereas Hydrogen doubles the achievable power output.
The mechanical efficiency of a kinematic SE is largely dependent on the load that is transferred from the pistons to the crankshaft during expansion and vice versa during compression, as it increases frictional losses. In double-acting engines an identical pressure oscillation acts on the opposing faces of a piston, although it is out of phase. The resulting forces can balance each other to some extent depending on the phase, and thus the net force applied to the crankshaft can be reduced. For a four cylinder engine it is shown that the Siemens arrangement balances internal forces on the pistons to a larger extent than the Franchot arrangement, so that the mechanical losses are inherently smaller and thus the brake power is larger even though the indicated work is identical for both engine types.
The contribution of this work is the provision of a modelling methodology, and the identification of a number of insights for system-design considerations for low-temperature applications
Cooperation of N- and C-terminal substrate transmembrane domain segments in intramembrane proteolysis by γ-secretase
Intramembrane proteases play a pivotal role in biology and medicine, but how these proteases decode cleavability of a substrate transmembrane (TM) domain remains unclear. Here, we study the role of conformational flexibility of a TM domain, as determined by deuterium/hydrogen exchange, on substrate cleavability by gamma-secretase in vitro and in cellulo. By comparing hybrid TMDs based on the natural amyloid precursor protein TM domain and an artificial poly-Leu non-substrate, we find that substrate cleavage requires conformational flexibility within the N-terminal half of the TMD helix (TM-N). Robust cleavability also requires the C-terminal TM sequence (TM-C) containing substrate cleavage sites. Since flexibility of TM-C does not correlate with cleavage efficiency, the role of the TM-C may be defined mainly by its ability to form a cleavage-competent state near the active site, together with parts of presenilin, the enzymatic component of gamma-secretase. In sum, cleavability of a gamma-secretase substrate appears to depend on cooperating TM domain segments, which deepens our mechanistic understanding of intramembrane proteolysis. Deuterium/hydrogen exchange shows that conformational flexibility of the hybrid transmembrane domains (TMD) of amyloid precursor proteins plays a role in TMD cleavability by gamma-secretase in vitro and in cellulo
Prospective randomized study of hemodialysis membrane biocompatibility in acute renal failure
Prostate Cancer Risk Is not Altered by TP53AIP1 Germline Mutations in a German Case-Control Series
Prostate cancer susceptibility has previously been associated with truncating germline variants in the gene TP53AIP1 (tumor protein p53 regulated apoptosis inducing protein 1). For two apparently recurrent mutations (p.Q22fs and p.S32X) a remarkable OR of 5.1 was reported for prostate cancer risk. Since these findings have not been validated so far, we genotyped p.Q22fs and p.S32X in two German series with a total of 1,207 prostate cancer cases and 1,495 controls. The truncating variants were not significantly associated with prostate cancer in none of the two cohorts, nor in the combined analysis [odds ratio (OR) = 1.16; 95% confidence interval (CI 95%) = 0.62–2.15; p = 0.66]. Carriers showed no significant differences in family history of prostate cancer, age at diagnosis, Gleason score or PSA at diagnosis when compared to non-carrier prostate cancer cases. The large sample size of the combined cohort rejects a high-risk effect greater than 2.2 and indicates a limited role of TP53AIP1 in prostate cancer predisposition
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene
To date, germline mutations have been found in three candidate genes for hereditary prostate cancer: ELAC2 at 17p11, RNASEL at 1q25 and MSR1 at 8p22. RNASEL, encoding the 2′,5′-oligoadenylate-dependant RNase L, seems to have rare mutations in different ethnicities, such as M1I in Afro-Americans, E265X in men of European descent and 471delAAAG in Ashkenazi Jews. In order to evaluate the relevance of RNASEL in the German population, we sequenced its open reading frame to determine the spectrum and frequency of germline mutations. The screen included 303 affected men from 136 Caucasian families, of which 45 met the criteria for hereditary prostate cancer. Variants were analysed using a family-based association test, and genotyped in an additional 227 sporadic prostate cancer patients and 207 controls. We identified only two sib pairs (1.4% of our families) cosegregating conspicuous RNASEL variants with prostate cancer: the nonsense mutation E265X, and a new amino-acid substitution (R400P) of unknown functional relevance. Both alleles were also found at low frequencies (1.4 and 0.5%, respectively) in controls. No significant association of polymorphisms (I97L, R462Q and D541E) was observed, neither in case–control analyses nor by family-based association tests. In contrast to previous reports, our study does not suggest that common variants (i.e. R462Q) modify disease risk. Our results are not consistent with a high penetrance of deleterious RNASEL mutations. Due to the low frequency of germline mutations present in our sample, RNASEL does not have a significant impact on prostate cancer susceptibility in the German population
Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations
Background: Mutations in the bone morphogenetic protein receptor 2 (BMPR2) gene can lead to idiopathic pulmonary arterial hypertension (IPAH). This study prospectively screened for BMPR2 mutations in a large cohort of PAH-patients and compared clinical features between BMPR2 mutation carriers and non-carriers. Methods: Patients have been assessed by right heart catheterization and genetic testing. In all patients a detailed family history and pedigree analysis have been obtained. We compared age at diagnosis and hemodynamic parameters between carriers and non-carriers of BMPR2 mutations. In non-carriers with familial aggregation of PAH further genes/gene regions as the BMPR2 promoter region, the ACVRL1, Endoglin, and SMAD8 genes have been analysed. Results: Of the 231 index patients 22 revealed a confirmed familial aggregation of the disease (HPAH), 209 patients had sporadic IPAH. In 49 patients (86.3% of patients with familial aggregation and 14.3% of sporadic IPAH) mutations of the BMPR2 gene have been identified. Twelve BMPR2 mutations and 3 unclassified sequence variants have not yet been described before. Mutation carriers were significantly younger at diagnosis than non-carriers (38.53 ± 12.38 vs. 45.78 ± 11.32 years, p < 0.001) and had a more severe hemodynamic compromise. No gene defects have been detected in 3 patients with HPAH. Conclusion: This study identified in a large prospectively assessed cohort of PAH- patients new BMPR2 mutations, which have not been described before and confirmed previous findings that mutation carriers are younger at diagnosis with a more severe hemodynamic compromise. Thus, screening for BMPR2 mutations may be clinically useful
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG
BACKGROUND In spite of intensive efforts, understanding of the genetic aspects of familial prostate cancer (PC) remains largely incomplete. In a previous microsatellite‐based linkage scan of 1,233 PC families, we identified suggestive evidence for linkage (i.e., LOD ≥ 1.86) at 5q12, 15q11, 17q21, 22q12, and two loci on 8p, with additional regions implicated in subsets of families defined by age at diagnosis, disease aggressiveness, or number of affected members. METHODS In an attempt to replicate these findings and increase linkage resolution, we used the Illumina 6000 SNP linkage panel to perform a genome‐wide linkage scan of an independent set of 762 multiplex PC families, collected by 11 International Consortium for Prostate Cancer Genetics (ICPCG) groups. RESULTS Of the regions identified previously, modest evidence of replication was observed only on the short arm of chromosome 8, where HLOD scores of 1.63 and 3.60 were observed in the complete set of families and families with young average age at diagnosis, respectively. The most significant linkage signals found in the complete set of families were observed across a broad, 37 cM interval on 4q13–25, with LOD scores ranging from 2.02 to 2.62, increasing to 4.50 in families with older average age at diagnosis. In families with multiple cases presenting with more aggressive disease, LOD scores over 3.0 were observed at 8q24 in the vicinity of previously identified common PC risk variants, as well as MYC , an important gene in PC biology. CONCLUSIONS These results will be useful in prioritizing future susceptibility gene discovery efforts in this common cancer. Prostate 72:410–426, 2012. © 2011 Wiley Periodicals, Inc.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90245/1/21443_ftp.pd
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.
BACKGROUND: Genetic variants are likely to contribute to a portion of prostate cancer risk. Full elucidation of the genetic etiology of prostate cancer is difficult because of incomplete penetrance and genetic and phenotypic heterogeneity. Current evidence suggests that genetic linkage to prostate cancer has been found on several chromosomes including the X; however, identification of causative genes has been elusive. METHODS: Parametric and non-parametric linkage analyses were performed using 26 microsatellite markers in each of 11 groups of multiple-case prostate cancer families from the International Consortium for Prostate Cancer Genetics (ICPCG). Meta-analyses of the resultant family-specific linkage statistics across the entire 1,323 families and in several predefined subsets were then performed. RESULTS: Meta-analyses of linkage statistics resulted in a maximum parametric heterogeneity lod score (HLOD) of 1.28, and an allele-sharing lod score (LOD) of 2.0 in favor of linkage to Xq27-q28 at 138 cM. In subset analyses, families with average age at onset less than 65 years exhibited a maximum HLOD of 1.8 (at 138 cM) versus a maximum regional HLOD of only 0.32 in families with average age at onset of 65 years or older. Surprisingly, the subset of families with only 2-3 affected men and some evidence of male-to-male transmission of prostate cancer gave the strongest evidence of linkage to the region (HLOD = 3.24, 134 cM). For this subset, the HLOD was slightly increased (HLOD = 3.47 at 134 cM) when families used in the original published report of linkage to Xq27-28 were excluded. CONCLUSIONS: Although there was not strong support for linkage to the Xq27-28 region in the complete set of families, the subset of families with earlier age at onset exhibited more evidence of linkage than families with later onset of disease. A subset of families with 2-3 affected individuals and with some evidence of male to male disease transmission showed stronger linkage signals. Our results suggest that the genetic basis for prostate cancer in our families is much more complex than a single susceptibility locus on the X chromosome, and that future explorations of the Xq27-28 region should focus on the subset of families identified here with the strongest evidence of linkage to this region.RIGHTS : This article is licensed under the BioMed Central licence at http://www.biomedcentral.com/about/license which is similar to the 'Creative Commons Attribution Licence'. In brief you may : copy, distribute, and display the work; make derivative works; or make commercial use of the work - under the following conditions: the original author must be given credit; for any reuse or distribution, it must be made clear to others what the license terms of this work are
- …